select trial semaglutide results Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design Effect of once-weekly subcutaneous semaglutide

5Amino1MQ Peptide (NNMTi), full name 5Amino1methylquinolinium chloride, is a highly selective smallmolecule peptide inhibitor targeting NNMT

Central role of the P2Y12 receptor in platelet activation

Lixisenatide therapy in older patients with type 2 diabetes inadequately controlled on their current antidiabetic treatment: the getgoal-o randomized trial

Other research has shown that omega-3s improve nerve structure in diabetes, and they are considered safe at daily doses of up to 3 grams of combined EPA and DHA

.

The search for comprehensive and combination therapies for cancer, particularly strategies that target cysteine or cysteine metabolism, has shown promising results